TEAKA GREEN: Open Payments
NPI 1346931367 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$818 in 23 payments from 12 companies in 2025. Trend: 2023 $128 · 2024 $431 · 2025 $818
Food & beverage: $724Education: $94
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $170 |
| Mallinckrodt Hospital Products Inc. | 4 | $155 |
| AKEBIA THERAPEUTICS INC | 2 | $152 |
| Vantive US Healthcare LLC | 1 | $150 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $49 |
| Novo Nordisk Inc | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| Aurinia Pharma U.S., Inc. | 1 | $22 |
| Apellis Pharmaceuticals, Inc. | 1 | $19 |
Products named: ACTHAR, Renal - Acute, Vafseo, LOKELMA, FARXIGA, JARDIANCE, Rybelsus, Auryxia.
Industry payments across GA — which companies pay providers there.
